Gilead Ditches Double-Patenting Claim In Tamiflu Suit
A New Jersey federal judge ruled Friday that Gilead Sciences Inc. did not unlawfully extend a patent for its flu drug Tamiflu, squashing generics maker Natco Pharma Ltd.'s bid to invalidate...To view the full article, register now.
Already a subscriber? Click here to view full article